Rivaroxaban 10mg Tablet in PCD pharma franchise in Hyderabad

Rivaroxaban 10mg Tablet in pharmaceutical manufacturing company in Mumbai

Rivaroxaban 10mg Tablet in anticoagulant pharma franchise in Pune

Rivaroxaban 10mg Tablet in pharma suppliers in Delhi

Rivaroxaban 10mg Tablet in pharma export companies in Kolkata
Rivaroxaban 10mg Tablet in pharma franchise opportunities in Bengaluru

Rivaroxaban 10 mg tablet

Composition : Rivaroxaban 10 mg tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10x14

Price : ₹1/-

Please Contact For Best Price

Rivaroxaban 10 Tablet is an oral anticoagulant belonging to the class of direct Factor Xa inhibitors. It works by selectively inhibiting Factor Xa, a key enzyme in the blood coagulation cascade, thereby reducing the risk of blood clot formation. This medication provides predictable anticoagulant effects with minimal need for routine monitoring, making it a convenient option for patients at risk of thromboembolic events.

Read More

About the Product

Rivaroxaban 10 Tablet is an oral anticoagulant belonging to the class of direct Factor Xa inhibitors. It works by selectively inhibiting Factor Xa, a key enzyme in the blood coagulation cascade, thereby reducing the risk of blood clot formation. This medication provides predictable anticoagulant effects with minimal need for routine monitoring, making it a convenient option for patients at risk of thromboembolic events.

Possible side effects include bleeding (such as nosebleeds, gastrointestinal bleeding, or bruising), headache, dizziness, and nausea. Serious but rare side effects may include liver enzyme elevations and hypersensitivity reactions. Bleeding risks are increased in patients with renal impairment or concurrent use of other anticoagulants or antiplatelets.

Rivaroxaban 10 mg Tablet is indicated for the prevention of venous thromboembolism (VTE) in patients undergoing elective hip or knee replacement surgery. It is also used for the treatment and secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in appropriate clinical settings, as directed by a healthcare provider.

Use only under medical supervision. Not recommended for patients with active bleeding, severe hepatic impairment, or those with prosthetic heart valves. Dose adjustments may be required based on kidney function. Avoid abrupt discontinuation unless directed by a physician, as it may increase the risk of thrombotic events.

Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch